Efficacy of interspinous device versus surgical decompression in the treatment of lumbar spinal stenosis: a modified network analysis. by Chou, Dean et al.
UCSF
UC San Francisco Previously Published Works
Title
Efficacy of interspinous device versus surgical decompression in the treatment of 
lumbar spinal stenosis: a modified network analysis.
Permalink
https://escholarship.org/uc/item/3wn71767
Journal
Evidence-based spine-care journal, 2(1)
ISSN
1663-7976
Authors
Chou, Dean
Lau, Darryl
Hermsmeyer, Jeffrey
et al.
Publication Date
2011-02-01
DOI
10.1055/s-0030-1267086
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Volume 2/Issue 1 — 2011 
45
Evidence-Based Spine-Care Journal
Systematic review—Efficacy of interspinous device versus surgical decompression in the treatment (...)
45—56 
Efficacy of interspinous device versus surgical 
decompression in the treatment of lumbar 
spinal stenosis: a modified network analysis
Authors Dean Chou¹, Darryl Lau², Jeffrey Hermsmeyer³, Daniel Norvell³
Institutions ¹ University of California, San Francisco, CA, USA
² University of Michigan Medical School, Ann Arbor, MI, USA
³ Spectrum Research Inc, Tacoma, WA, USA
ABSTRACT
Study design: Systematic review using a modified network analysis.
Objectives: To compare the effectiveness and morbidity of interspinous-device placement versus surgical 
decompression for the treatment of lumbar spinal stenosis.
Summary: Traditionally, the most effective treatment for degenerative lumbar spinal stenosis is through 
surgical decompression. Recently, interspinous devices have been used in lieu of standard laminectomy. 
Methods: A review of the English-language literature was undertaken for articles published between 
1970 and March 2010. Electronic databases and reference lists of key articles were searched to identify 
studies comparing surgical decompression with interspinous-device placement for the treatment of 
lumbar spinal stenosis. First, studies making the direct comparison (cohort or randomized trials) 
were searched. Second, randomized controlled trials (RCTs) comparing each treatment to conserva-
tive management were searched to allow for an indirect comparison through a modified network 
analysis approach. Comparison studies involving simultaneous decompression with placement of an 
interspinous device were not included. Studies that did not have a comparison group were not included 
since a treatment effect could not be calculated. Two independent reviewers assessed the strength of 
evidence using the GRADE criteria assessing quality, quantity, and consistency of results. The strengths 
of evidence for indirect comparisons were downgraded. Disagreements were resolved by consensus.
Results: We identified five studies meeting our inclusion criteria. No RCTs or cohort studies were identi-
fied that made the direct comparison of interspinous-device placement with surgical decompres-
sion. For the indirect comparison, three RCTs compared surgical decompression to conservative 
management and two RCTs compared interspinous-device placement to conservative management. 
There was low evidence supporting greater treatment effects for interspinous-device placement 
compared to decompression for disability and pain outcomes at 12 months. There was low evidence 
demonstrating little to no difference in treatment effects between the groups for walking distance 
and complication rates. 
Conclusion: The indirect treatment effect for disability and pain favors the interspinous device compared 
to decompression. The low evidence suggests that any further research is very likely to have an 
important impact on the confidence in the estimate of effect and is likely to change the estimate. No 
significant treatment effect differences were observed for postoperative walking distance improve-
ment or complication rates; however, findings should be considered with caution because of indirect 
comparisons and short follow-up periods.
This systematic review was funded by AOSpine
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STUDY RATIONALE AND CONTEXT
Traditionally, the most effective treatment for degenerative 
lumbar spinal stenosis is through surgical decompression 
[1]. Recently, interspinous devices have been used in lieu 
of standard laminectomy. The idea of using a device to 
distract the spinous processes for symptomatic relief is not 
new. It was first used in the 1950s but was abandoned sec-
ondary to device dislodgement, poor clinical indications, 
and implant malfunction. It is only recently that inter-
spinous devices are being more popularized with various 
designs (from static spacers to dynamic devices) composed 
of an array of materials including allograft, titanium, 
polyetheretherketone, and elastomeric compounds. The 
mechanical mechanism by which interspinous devices are 
purported to treat spinal stenosis is to focally create slight 
spinal flexion by distraction of the spinous processes. This 
mimics the position of sitting, which increases the room 
for the nerves, potentially alleviating pain. Implantation of 
interspinous devices is a relatively straightforward surgical 
procedure and can be performed under local anesthesia. 
However, it is important to clearly identify evidence of 
whether interspinous devices are able to provide effective 
treatment and achieve similar goals to surgical decompres-
sion for degenerative lumbar spinal stenosis. In addition, 
the placement of interspinous devices is touted to be less 
morbid than a standard surgical decompression.
OBJECTIVES 
•	 To compare the effectiveness of interspinous-device 
placement versus surgical decompression for the treat-
ment of lumbar spinal stenosis.
•	 To compare the morbidity of interspinous-device 
placement versus surgical decompression for the treat-
ment of lumbar spinal stenosis.
MATERIALS AND METHODS
Study design: Systematic review using a modified net-
work analysis for indirect comparisons.
Sampling:
•	 Search: PubMed, Cochrane collaboration database, 
and National Guideline Clearinghouse databases; 
bibliographies of key articles.
•	 Dates searched: 1970 through March 2010.
Inclusion criteria: Patients with lumbar spinal stenosis. 
Randomized controlled trials (RCTs) and nonran-
domized comparison studies. RCTs only for indirect 
comparisons. 
Exclusion criteria: Trauma, significant lumbar instabil-
ity, previous lumbar spine surgery, spondylolisthesis 
> grade I and patient younger than 40 years. Com-
parison studies involving decompression surgery 
with simultaneous interspinous-device placement. 
Case series of interspinous-device placement or de-
compression surgery were not included because of 
the inability to calculate treatment effects without 
a comparison group. 
Outcomes: Disability, pain, function, and morbidity 
measures.
Analysis: Changes in outcome scores from baseline to 
follow-up and complication rates were extracted 
for all studies. Treatment effects were calculated 
by comparing change scores between treatment 
groups. For the studies without a direct comparison 
between surgical decompression and interspinous-
device placement, a modified network analysis 
for indirect treatment comparisons was made. 
The treatment effect was calculated by compar-
ing the treatment effects of decompression versus 
conservative management to the treatment effects 
of interspinous-device placement to conservative 
management. Mean treatment effects between stud-
ies were compared. Complications were pooled; 
however, scores from functional measures were 
not pooled. Two independent reviewers assessed 
the strength of evidence using the GRADE criteria 
assessing quality, quantity, and consistency of re-
sults. Quality of evidence was downgraded for indi-
rect comparisons and for small number of studies. 
Details about methods can be found in the electronic supple-
mental material at www.aospine.org/ebsj 
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RESULTS
We identified 97 citations and reviewed 85 abstracts. Af-
ter abstract review, we excluded 72 studies that did not 
meet inclusion/exclusion criteria. We reviewed 13 full-
text articles. Eight of these were excluded, leaving five 
studies meeting our inclusion criteria (Fig 1). No RCTs or 
cohort studies making the direct comparison were identi-
fied; however, one study compared decompression with 
interspinous-device placement to decompression only 
[2] and one compared interspinous-device placement to 
decompression with instrumented fusion [3]; therefore, 
they were excluded. Three RCTs compared surgical de-
compression to conservative management and two RCTs 
compared interspinous-device placement to conservative 
management. These five studies were selected and used 
to perform indirect comparisons through a modified net-
work analysis. All studies included subjects who had failed 
conservative management. Details of each study can be 
found in Tables 1 and 2. 
Description of included studies
•	 Treatment effects comparing decompression to conser-
vative management were compared to the treatment 
effects comparing interspinous-device placement only 
to conservative management in different RCTs (modi-
fied network analysis).
•	 RCT 1 compared surgical decompression only (n = 50) with 
nonoperative treatment consisting of nonsteroidal antiin-
flammatory drugs and physical therapy (n = 44) [4]. 
•	 RCTs 2 and 3 (two studies) were combined as we used 
data from both studies which included 2- and 4-year 
follow-ups, respectively. Patients were either assigned 
to a surgical decompression-only group (n = 138) or to 
a nonoperative group consisting of physical therapy, 
nonsteroidal antiinflammatory drugs and epidural in-
jections (n = 151) [1, 5]. These studies analyzed data 
with an intent-to-treat analysis and with an as-treated 
analysis separately. We summarized the intent-to-treat 
analysis because the RCT that it is compared to also 
analyzed data by intent to treat. 
•	 RCTs 4 and 5 (two studies) were combined as we used 
data from both studies that included 1- and 2-year 
follow-ups, respectively. Patients were either assigned 
to an interspinous-device placement group (n = 100) or 
to a nonoperative group consisting of physical therapy, 
nonsteroidal antiinflammatory drugs, analgesics, and at 
least one epidural steroid injection (n = 91) [6, 7].
Disability outcomes comparing interspinous devices to 
decompression 
The two treatments can be compared indirectly in the 
RCTs by Zucherman et al [6, 7] and Weinstein et al [1, 5] 
since they used the same outcomes measures (SF-36 Physi-
cal Function scores, respectively) (Table 3). The 12-month 
indirect treatment effect was 18.4 (20 versus 1.6) points 
using the SF-36 Physical Function score [1, 5–7] (Fig 2).  
Pain outcomes comparing interspinous-device placement 
to surgical decompression 
•	 Differences in pain were observed through indirect 
comparisons. The RCTs by Weinstein et al [1, 5] and 
Zucherman et al [6, 7] measured change in SF-36 
bodily pain scores at 12 months. The improvement 
in pain score was 23 and 31 points for the surgical 
decompression and interspinous groups, respectively 
(Table 3). When compared to the conservative groups, 
the treatment effects were 5.5 and 22 points, respec-
tively. Therefore, the greater pain treatment effect (16.5 
points) was observed in the interspinous group (Fig 2).
•	 Weinstein et al [1, 5] administered several other pain 
measures including a Low Back Pain Bothersome 
score, Leg Pain Bothersome score, and a Stenosis Both-
ersome score. When comparing the decompression 
to conservative management groups, the treatment 
effects were not statistically significant (Table 2).
Functional outcomes comparing interspinous-device place-
ment to surgical decompression 
•	 The indirect treatment effects for improvement in walk-
ing distances comparing decompression (Malmivaara et 
al [4]) and interspinous (Zucherman et al [6, 7]) groups 
to conservative groups were 23% and 25%, respectively 
(Table 3 and Fig 2).
Safety outcomes comparing interspinous-device place-
ment to surgical decompression
•	 The two RCTs by Malmivaara et al [4] and Weinstein 
et al [1, 5] reported 27% and 11.6% complication rates 
(perioperative and postoperative complications) in the 
surgical decompression groups compared to 0% in the 
conservative groups at 12 months, respectively. The 
RCT by Zucherman et al [6, 7] reported an 11% com-
plication rate in the interspinous group compared to 
0% in the conservative group. 
•	 The pooled complication rate for decompression was 
15.2% and the complication rate for the interspinous 
device was 11% (c2 P = .33) (Fig 2). 
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Table 1 Demographics of studies for lumbar spinal stenosis (LSS) treated by decompression or interspinous device.
Reference Study design
Study
population Treatment description Inclusion and exclusion criteria
Follow-up time,
% F/U
M
al
m
iv
aa
ra
et
 a
l (
20
07
) [
4]
Randomized 
controlled trial
December 
1997–March 2001
N = 94
Decompression 
 – n = 50
 – Age: 63 ± 9 y
 – Male: 22% 
Nonoperative 
treatment
 – n = 44
 – Age: 62 ± 9 y
 – Male: 45% 
Decompression:
 – Segmental decompression 
 – Undercutting facetectomy 
 – Fusion if instability present or 
if a risk of instability
Nonoperative:
 – Nonsteroidal 
antiinflammatory drugs 
 – Physical therapy consisting of 
body posture, trunk 
strengthening, stretching 
exercise, modalities
Inclusion:
 – Clinical and x-ray symptomatic LSS
 – Duration of symptoms > 6 mo
 – Failed conservative treatment
 – Persistent pain without progressive 
neurological dysfunction
Exclusion:
 – Severe LSS with intractable pain and 
progressive neurological dysfunction
 – Mild LSS feeble enough to exclude 
surgery
 – Stenosis not caused by degeneration
 – Spondylolytic spondylolisthesis
 – Previous lumbar spine surgery
 – Diagnosed lumbar herniated disc 
 – Other spinal disorders
 – Severe osteoarthritis causing lower limb 
dysfunction
24 mo:
 – Decompression: 86%
 – Nonoperative: 91%
12 mo:
 – Decompression: 96%
 – Nonoperative: 93%
6 mo:
 – Decompression: 88%
 – Nonoperative: 93%
Available for all 
follow-ups:
 – Decompression: 86%
 – Nonoperative: 84%
W
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 e
t a
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1,
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]
Randomized 
controlled trial 
intent-to-treat 
analysis
March 
2000– March 
2005
N = 289
 – Age: 65.5 ± 10.5 y
 – Male: 62%
Assigned to 
decompression group
 – n = 138
 – Age: not reported (NR)
 – Male: NR
Assigned to 
nonoperative treatment 
group
 – n = 151
 – Age: NR
 – Male: NR
Decompression:
 – Standard posterior 
decompression laminectomy
Nonoperative:
 – Physical therapy 
 – Home exercise instruction
 – Epidural injections
 – Chiropractic care
 – Nonsteroidal 
antiinflammatory drugs 
 – Opioid analgesics
Inclusion:
 – X-ray confirmation of LSS
 – History of neurogenic claudication or 
radicular leg symptoms >12 weeks
 – One or more levels
 – All patients judged to be surgical 
candidates
Exclusion:
 – Lumbar instability
 – Patients with degenerative 
spondylolisthesis studied separately
48 mo:
 – Decompression: 67%
 – Nonoperative: 64%
24 mo:
 – Decompression: 79%
 – Nonoperative: 75%
12 mo:
 – Decompression: 87%
 – Nonoperative: 83%
6 mo:
 – Decompression: 87%
 – Nonoperative: 89%
Zu
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]
Randomized 
controlled trial
May 2000–July 
2001
N = 191
 – Age: 69.5 y
 – Male: NR
Interspinous device
 – n = 100
 – Age: 70 y
 – Male: 57%
Nonoperative 
treatment 
 – n = 91
 – Age: 69 y
 – Male: 52%
Interspinous device:
 – Mid-sagittal incision made 
over spinous processes of 
stenotic levels
 – Hypertrophied facets that 
blocked entry to anterior 
interspinous space trimmed
 – X STOP interspinous device 
implanted at one or two levels
Nonoperative:
 – Physical therapy consisting of 
back school, stabilization 
exercises, massage and 
modalities
 – Received at least one epidural 
steroid injection
 – Nonsteroidal 
antiinflammatories
 – Analgesics
 – Braces, such as abdominal 
binders and corsets, were 
permitted
Inclusion:
 – X-ray confirmation of LSS
 – Leg, buttock, or groin pain with or 
without back pain relieved during flexion
 – ≥50 y
 – One or two levels
 – Able to sit pain free for 50 min
 – Walk >50 feet 
 – Completed 6 mo of nonoperative 
therapy
Exclusion:
 – Fixed motor deficit
 – Cauda equina syndrome
 – Significant lumbar instability
 – Previous lumbar surgery
 – Significant peripheral neuropathy or 
acute denervation secondary to 
radiculopathy
 – Spondylolisthesis > grade I
 – Sustained pathological fractures
 – Severe osteoporosis of vertebrae 
 – Active infection or systemic disease
 – Paget disease or metastasis of vertebrae
24 mo:
 – Interspinous device: 
93%
 – Nonoperative: 89%
12 mo:
 – Interspinous device: 
88%
 – Nonoperative: 75%
6 mo:
 – Interspinous device: 
88%
 – Nonoperative: 69%
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Table 2 Clinical outcomes and complications for lumbar spinal stenosis (LSS) treated by decompression or interspinous device.
So
u
rc
e Clinical outcomes Other outcomes
6 months 12 months 24 months 48 months
M
al
m
iv
aa
ra
 e
t a
l (
20
07
) [
4]
Oswestry Disability Index:
 – Decomp: –13.3 (34–20.7)
 – Nonop: –6.4 (34.7–28.3)
Treatment effect: –6.9 
(95% CI: 1.3–13.9)
Numeric Rating Scale for leg 
pain during walking:
 – Decomp: –4.01 
(6.58–2.57)
 – Nonop: –1.71 (6.3–4.59)
Treatment effect: –2.30 
(95% CI: 0.69–3.36)
Numeric Rating Scale for low 
back pain during walking:
 – Decomp: –4.09 (6.9–2.81)
 – Nonop: –1.38 (6.83–5.45)
Treatment effect: –2.71 
(95% CI: 1.40–3.88)
Increase in walking distance, 
meters:
 – Decomp: 1503 
(1321–2824)
 – Nonop: 1274 (1321–2638)
Treatment effect : 229 
(95% CI: –1394–1022)
Oswestry Disability Index:
 – Decomp: –15.1 (34–19)
 – Nonop: –4.5 (34.7–30.2)
Treatment effect: –10.6 
(95% CI: 4.3–18.4)
Numeric Rating Scale for leg 
pain during walking:
 – Decomp: –3.85  
(6.58– 2.73)
 – Nonop: –1.89 (6.3– 4.41)
Treatment effect: –1.96 
(95% CI: 0.41–2.96)
Numeric Rating Scale for low 
back pain during walking:
 – Decomp: –4.18 (6.9–2.72)
 – Nonop: –1.78 (6.83–5.05)
Treatment effect: –2.40 
(95% CI: 1.12–3.55)
Increase in walking distance, 
meters:
 – Decomp: 1721 
(1321–3042)
 – Nonop: 1460 (1364–2824)
Treatment effect : 261
Improvement: 130% 
(95% CI: –1523–1087)
Oswestry Disability Index:
 – Decomp: –12.8 (34–21.2)
 – Nonop: –5.7 (34.7–29)
Treatment effect: –7.1 
(95% CI: 0.8–14.9)
Numeric Rating Scale for leg 
pain during walking:
 – Decomp: –3.54  
(6.58– 3.04)
 – Nonop: –1.75 (6.3– 4.55)
Treatment effect: –1.79 
(95% CI: 0.25–2.77)
Numeric Rating Scale for low 
back pain during walking:
 – Decomp: –4.16 (6.9–2.74)
 – Nonop: –1.96 (6.83– 4.87)
Treatment effect: –2.20 
(95% CI: 0.98–3.28)
Increase in walking distance, 
meters:
 – Decomp: 1508 
(1321–2829)
 – Nonop: 1414 (1364–2778)
Treatment effect : 94 
Improvement: 114% 
(95% CI: –1338–1235)
Not reported Complications: 
 – 8 perioperative complications including 
7 lesions to dural sac corrected with 
sutures and 1 misplaced transpedicular 
screw replaced during original surgery
 – 1 postoperative complication of 
respiratory distress due to pulmonary 
edema combined with stress ulcer
Revision/additional surgery:
 – 4 (9%) patients in nonoperative group 
required surgery because of 
exacerbation of symptoms 
 – 3 (6%) further surgeries in 
decompression group; 1 as a result of 
misjudgment of stenotic level corrected 
same day; 1 due to peridural hematoma 
at 3 days; 1 patient had a new 
decompressive procedure at  
12 mo
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Oswestry Disability Index:
Mean change
 – Decomp: –14.6 ± 1.9
 – Nonop: –13.7 ± 1.7
Treatment effect: –0.9 
(95% CI: –5.9– 4.1)
SF-36 Bodily pain:
Mean change
 – Decomp: 21.0 ± 2.2
 – Nonop: 16.1 ± 2.1
Treatment effect: 4.9 
(95% CI: –1.2–10.9)
SF-36 Physical function:
Mean change
 – Decomp: 17.6 ± 2.3
 – Nonop:15.1 ± 2.2
Treatment effect: 2.5 
(95% CI: –3.7– 8.6)
Stenosis Bothersome Index:
NR
Leg Pain Bothersome Index:
NR
Low Back Pain Bothersome 
Index:
NR
Oswestry Disability Index:
Mean change
 – Decomp: –14.9 ± 1.9
 – Nonop: –12.7 ± 1.8
Treatment effect: –2.2 
(95% CI: –7.4–2.9)
SF-36 Bodily pain:
Mean change
 – Decomp: 23.0 ± 2.3
 – Nonop: 17.5 ± 2.2
Treatment effect: 5.5 
(95% CI: –0.7–11.7)
SF-36 Physical function:
Mean change
 – Decomp: 18.0 ± 2.3
 – Nonop: 16.4 ± 2.2
Treatment effect: 1.6 
(95% CI: –4.8–7.9)
Stenosis Bothersome Index:
Mean change
 – Decomp: –6.1 ± 0.7
 – Nonop: –4.9 ± 0.7
Treatment effect: –1.2 
(95% CI: –3.2– 0.8)
Leg Pain Bothersome Index:
Mean change
 – Decomp: –2.3 ± 0.2
 – Nonop: –1.7 ± 0.2
Treatment effect: –0.6 
(95% CI: –1.3–0)
Low Back Pain Bothersome 
Index:
Mean change
 – Decomp: –1.3 ± 0.2
 – Nonop: –1.3 ± 0.2
Treatment effect: 0 
(95% CI: –0.5–0.6)
Oswestry Disability Index:
Mean change
 – Decomp: –16.4 ± 1.9
 – Nonop: –12.9 ± 1.8
Treatment effect: –3.5 
(95% CI: –8.7–1.7)
SF-36 Bodily pain:
Mean change
 – Decomp: 23.4 ± 2.3
 – Nonop: 15.6 ± 2.2
Treatment effect: 7.8 
(95% CI: 1.5–14.1)
SF-36 Physical function:
Mean change
 – Decomp: 17.1 ± 2.4
 – Nonop: 17.1 ± 2.3
Treatment effect: 0.1 
(95% CI: –6.4–6.5)
Stenosis Bothersome Index:
Mean change
 – Decomp: –6.3 ± 0.7
 – Nonop: –5.6 ± 0.7
Treatment effect: –0.7 
(95% CI: –2.7–1.3)
Leg Pain Bothersome Index:
Mean change
 – Decomp: –2.2 ± 0.2
 – Nonop: –1.8 ± 0.2
Treatment effect: –0.3 
(95% CI: –1.0–0.3)
Low Back Pain Bothersome 
Index:
Mean change
 – Decomp: –1.3 ± 0.2
 – Nonop: –1.6 ± 0.2
Treatment effect: –0.3 
(95% CI: –0.2–0.9)
Oswestry Disability Index :
Mean change
 – Decomp: –12.2 ± 2.0
 – Nonop: –12.4 ± 1.9
Treatment effect: 0.2 
(95% CI: 5.2–5.7)
SF-36 Bodily pain:
Mean change
 – Decomp: 15.9 ± 2.4
 – Nonop: 15.7 ± 2.4
Treatment effect: 0.3 
(95% CI: –6.4–7.0)
SF-36 Physical function:
Mean change
 – Decomp: 12.7 ± 2.5
 – Nonop: 15.9 ± 2.4
Treatment effect: –3.2 
(95% CI: –9.9–3.6)
Stenosis Bothersome Index:
Mean change
 – Decomp: –5.2 ± 0.75
 – Nonop: –4.5 ± 0.73
Treatment effect: –0.7 
(95% CI: –2.8–1.4)
Leg Pain Bothersome Index:
Mean change
 – Decomp: –1.8 ± 0.2
 – Nonop: –1.8 ± 0.2
Treatment effect: 0 
(95% CI: –0.7–0.6)
Low Back Pain Bothersome 
Index:
Mean change
 – Decomp: –0.9 ± 0.2
 – Nonop: –1.3 ± 0.2
Treatment effect: 0.4 
(95% CI: –0.2–1.0)
Patient satisfaction, %:
 – Very or somewhat satisfied with 
symptoms
 – Very or somewhat satisfied with care
 – Self-rated major improvement in 
condition
6 mo:
Decompression and nonoperative: 
1. 49.9 and 38.3  
Treatment effect 11.7  
(95% CI: –0.8–24.1)
2. 85.0 and 73.1 
Treatment effect 11.9  
(95% CI: 1.9–21.9)
3. 49.0 and 46.2 
Treatment effect 2.8  
(95% CI: –10.0–15.5)
12 mo:
Decompression and nonoperative: 
1. 53.4 and 40.7 
Treatment effect 12.8  
(95% CI: –0.3–25.8)
2. 81.4 and 69.3 
Treatment effect 12.0  
(95% CI: 0.8–23.2)
3. 55.3 and 44.2 
Treatment effect 11.1 
(95% CI: –2.1–24.2)
24 mo:
Decompression and nonoperative: 
1. 53.1 and 45.0  
Treatment effect 8.1  
(95% CI: –5.3–21.5)
2. 76.2 and 68.5 
Treatment effect  
7.6 (95% CI: –4.5–19.7)
3. 50.7 and 45.0 
Treatment effect 5.8 
(95% CI: –7.8–19.3)
Complications of the 166/171 patients 
(surgical information available) who had 
surgery regardless of assigned group: 
Surgery:
 – Decompression only (88%)
 – Fusion (11%)
Death within 3 mo of surgery: 0%
Intraoperative complications:
 – Dural tear/spinal fluid leak: 9%
Postoperative complications:
 – Wound hematoma: 2%
 – Wound infection: 2%
Revision/additional surgery rate, %:
 – 1-y rate: 4
 – 2-y rate: 7
 – 3-y rate: 10
 – 4-y rate: 13 (n = 22)
Reason for additional surgery at 4 y (n = 22):
 – Recurrent stenosis/progressive 
spondylolisthesis: 15 (9%)
 – Complication: 6 (4%)
 – New condition: 1 (0.60%)
So
u
rc
e Clinical outcomes Other outcomes
6 months 12 months 24 months 48 months
Table 2 (Cont.)
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Zurich Claudication 
Questionnaire 
Overall success rates, %:
 – X STOP: 52
 – Nonop: 9
Symptom severity 
improvement rates, %:*
 – X STOP: 75
 – Nonop: 39
Physical function 
improvement rates, %:*
 – X STOP: 63
 – Nonop: 18
Satisfaction rates, %:*
 – X STOP: 65
 – Nonop: 42 
SF-36 
Mean change 
(Postoperative-preoperative)
Bodily pain:
 – X STOP: 31 (56–25)
 – Nonop: 9 (37–28)
Treatment effect: 22 
Physical function:
 – X STOP: 30 (62–32)
 – Nonop: 10 (43–33)
Treatment effect: 20 
Role physical:
 – X STOP: 43 (57–14)
 – Nonop: 15 (32–17)
Treatment effect: 28 
General health:
 – X STOP: 3 (73–70)
 – Nonop: –6 (64– 70)
Treatment effect: 9 
Vitality:
 – X STOP: 6 (53–47)
 – Nonop: 30 (47–17)
Treatment effect: –24 
Social function:
 – X STOP: 20 (79–59)
 – Nonop: 3 (67–64)
Treatment effect: 17 
Role emotional:
 – X STOP: 25 (77–52)
 – Nonop: 9 (58–49)
Treatment effect: 16 
Mental health:
 – X STOP: 2 (67–65)
 – Nonop: –1 (60–61)
Treatment effect: 3 
Zurich Claudication Questionnaire
Overall success rates, %
 – X STOP: 59
 – Nonop: 12
Symptom severity improvement rates, 
%*
 – X STOP: 77
 – Nonop: 30
Symptom severity (no or mild pain), 
%:
 – X STOP: 64
 – Nonop: 21
Physical function improvement rates, 
%*
 – X STOP: 71
 – Nonop: 23
Zurich Claudication 
Questionnaire
Mean % improvement in 
symptom severity domain 
score: (P < .001)
 – X STOP: baseline + 45.4%
 – Nonop: baseline + 7.4%
Mean % improvement in 
physical function domain 
score: (P < .001)
 – X STOP: baseline + 44.3%
 – Nonop: baseline - 0.4%
Symptom severity 
improvement rates, % 
(P < .001)
 – X STOP: 60.2
 – Nonop: 18.5
Physical function 
improvement rates, % 
(P < .001)
 – X STOP: 57
 – Nonop: 14.8
Satisfaction rates, %  
(P <  .001)
 – X STOP: 73.1
 – Nonop: 35.9
NR Surgical complications:
 – 1 (1%) episode of respiratory distress 
within 72 hours
 – 1 (1%) ischemic coronary episode that 
resolved without clinical sequelae
 – 1 (1%) patient with history of 
cardiovascular disease developed 
pulmonary edema
 – 1 (1%) wound dehiscence
 – 1 (1%) swollen wound that was aspirated
 – 1 (1%) hematoma
 – 1 (1%) report of incisional pain
 – 1 (1%) patient fell and the implant 
dislodged posteriorly
 – 1 (1%) patient had an asymptomatic 
spinous-process fracture diagnosed on 
follow-up x-ray that healed without any 
recurrence of symptoms
 – 1 (1%) patient reported worsening pain 
382 days after treatment which was 
determined to possibly be related to the 
implant
 – 1 (1%) implant was placed posterior 
enough to be considered malpositioned
Revision/additional surgery:
 – During 24-mo F/U 24 (30%) of 81 
patients in nonoperative group required 
decompressive surgery because of 
unresolved stenosis symptoms 
 – During 24-mo F/U 6 (6.4%) patients in X 
STOP group required decompressive 
surgery because of unresolved stenosis 
symptoms
Walking distance (patients able to walk 
10 blocks), %
 – X STOP: 75 (>2 blocks)
 – Nonop: 50 (>2 blocks)
Satisfaction rates, %*
 – X STOP: 71
 – Nonop: 50 
So
u
rc
e Clinical outcomes Other outcomes
6 months 12 months 24 months 48 months
* Absolute scores not given. Approximate mean change scores 
calculated from figures. 
Decomp indicates decompression; nonop, nonoperative;  
NR, not reported; CI, confidence interval; F/U, follow-up;  
and numbers within parentheses are ranges unless  
otherwise indicated.
Table 2 (Cont.)
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Table 4 Comparing 12- and 24-month mean percentage improvements in Zurich Claudication subscale scores and treatment effects between 
interspinous device and conservative management in the study by Zucherman et al [6, 7].
Improvement Interspinous Conservative Treatment effect
12 months 24 months 12 months 24 months 12 months 24 months
Physical function, % 71 57 23 14.8 48 42.2
Symptom severity, % 77 60.2 30 18.5 47 47.2
Table 5 Comparing 12- and 24-month improvements in the mean Oswestry Disability Index (ODI) scores and treatment effects between 
decompression and conservative management in the studies by Malmivaara et al [4] and Weinstein et al [1, 5], respectively.
Score Decompression Conservative Treatment effect
12 months 24 months 12 months 24 months 12 months 24 months
ODI (points) -15.1 -12.8 -4.5 -5.7 -10.6 -7.1
ODI (points) -14.9 -16.4 -12.7 -12.9 -2.2 -3.5
Negative scores represent improvement in function.
Table 3 Changes from baseline to 12 and 24 months postoperatively and corresponding treatment effects for indirect comparisons of each 
surgical arm to a conservative arm. 
Outcome Reference Patients, N Interspinous device Decom pression
Treatment effect 
A or B vs C
Total Rx arm(s) 12-mo change 24-mo change 12-mo change 24-mo change 12 mo 24 mo
Disability 
SF-36 Physical Function
Weinstein et al [1, 5] 289 B (138) — — 18.0 17.1 1.6 0.1
Zucherman et al [6, 7] 191 A (100) 30 NR — — 20 NR
Pain
SF-36 Bodily Pain
Weinstein et al [1, 5] 289 B (138) — — 23.0 23.4 5.5 7.8
Zucherman et al [6, 7] 191 A (100) 31 NR — — 22 NR
Function 
Walking distance
Malmivaara et al [4] 94 B (50) — — 130% 114% 23% 10%
Zucherman et al [6, 7] 191 A (100) 75% NR — — 25% NR
Safety 
Complication rates*
Malmivaara et al [4] 94 B (50) — — 27% NR 27% NR
Weinstein et al [1, 5] 289 B (138) — — 11.6% NR 11.6% 0
Zucherman et al [6, 7] 191 A (100) 11% NR — — 11% 0
Dashes represent treatment arms that were not included in the particular study. NR indicates not reported; Rx, treatment arms (A, interspinous device;  
B, decompression; C, conservative); and N, all subjects in study. Change in points at 12 months and 24 months if no units are listed; change is given in percentage.  
The lower the score, the higher the function.
Treatment effect indicates difference between interspinous (A) or decompression (B) versus conservative (C) arm change scores.
* All postoperative complications, except additional surgery.  
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1. Total citations
(n = 97)
3. Retrieved for full 
(n = 13)
2. Title/abstract 
(n = 85)
5. Publications
(n = 5)
4. Excluded at full-text 
(n = 8)
Fig 1 Results of literature search.
Interspinous
SF-36 Physical 
Function score 
(12 months)
TE = 18.4 points
TE = 16.5 points
TE = 2%
TE = 4%
Pain Score
(12 months)
Walking 
distance  
(%)
Complications 
(%)
Decompression30
25
20
15
10
5
0
Fig 2 Indirect treatment effects (TE)* comparing surgical 
decompression to interspinous-device placement. 
* Indirect treatment effects are based on the difference between decompression 
versus conservative management and interspinous-device placement versus 
conservative management. 
Outcomes Strength of evidence* Conclusions/Comments
1. Disability Very low Low Moderate High Indirect treatment effect favored the interspinous device 
compared to decompression 12 months after surgery using the 
SF-36 Physical Function score.
2. Pain Very low Low Moderate High Indirect treatment effect favored the interspinous device 
compared to decompression 12 months after surgery using the 
SF-36 Bodily Pain score.
3. Function Very low Low Moderate High No significant indirect treatment effect for walking distance at 12 
months comparing the two treatments.
4. Safety Very low Low Moderate High No significant differences in the complication rates between the 
interspinous device (11%) and decompression (15.2%).
* Low evidence indicates further research is likely to have an important impact on the confidence in the estimate of effect and is likely to change 
the estimate.
EVIDENCE SUMMARY
Table 6
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DISCUSSION
There was low evidence supporting greater treatment 
effects for interspinous-device placement compared to 
decompression for disability and pain outcomes at 12 
months. There was low evidence demonstrating little to no 
difference in treatment effects between groups for walking 
distance and complication rates. GRADE criteria suggest 
that low evidence indicates “further research is very likely 
to have an important impact on the confidence in the 
estimate of effect and is likely to change the estimate.”
The observations that are seen in this modified network 
analysis must be taken within the context that no direct 
comparisons between interspinous spacers and decom-
pressive laminectomy exist. Thus, the network analysis 
model analyzes best available evidence from the two dif-
ferent treatment studies for an indirect comparison. 
This indirect comparison must be carefully analyzed be-
cause of the inherent possibilities of different treatment 
groups (ie, heterogeneity).
 
The first caveat is the intent-to-treat analysis as opposed 
to an as-treated analysis. In the Weinstein et al study 
[1, 5] , 43% of the patients who were in the nonsurgical 
arm crossed over to having surgery at the 2-year mark. 
In addition, only 67% of the surgical arm had actually 
undergone surgery. In the article, the authors’ state, “ … 
the intention-to-treat analysis underestimates the true ef-
fect of surgery.” They go on to conclude, “In the as-treated 
analysis … those treated surgically showed significantly 
greater improvement … ” Further, none of the patients in 
Zucherman et al [6, 7] crossed over. Thus, because of the 
cross over in the Weinstein et al study [1, 5], the treatment 
effect may not be as great as that seen in the Zucherman 
et al study (Tables 4, 5) [6, 7].
Another point to consider is the difference in the enroll-
ment of patients. Weinstein et al [1, 5] and Malmivaara et 
al [4] enrolled patients who were diagnosed with lumbar 
stenosis who failed conservative therapy. Zucherman et 
al [6, 7], however, enrolled patients who had pain relief 
while sitting. Thus, the patients enrolled in that study were 
known to have alleviation of pain with their lumbar spines 
in flexion. This may have created a selection bias in that 
this study only enrolled patients who would respond favor-
ably to an interspinous device. 
Morbidity was calculated from the complication rates, 
both perioperatively and postoperatively. Note that both 
lumbar decompressive surgery groups (Weinstein et al 
[1, 5] and Malmivaara et al [4]) had patients with instru-
mented fusion (a more morbid procedure than decompres-
sion alone). This would have skewed the complication rate 
higher for the surgical decompression groups, since these 
were not simple decompressive procedures. 
The indirect treatment effect for disability and pain favors 
the interspinous device compared to decompression. No 
significant treatment effect differences were observed for 
postoperative-walking distance improvement or compli-
cation rates; however, findings should be considered with 
caution due to indirect comparisons and short follow-up 
periods.
 
Given the limitations of our network analysis, we none-
theless evaluated the best evidence currently available 
(Table 6). Eventually, studies with direct comparisons 
evaluating the efficacy between interspinous devices and 
surgical decompression will hopefully give a more precise 
answer. 
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EDITORIAL STAFF PERSPECTIVE
There are several noteworthy factors regarding this topic and 
the systematic review as performed:
•	  The current strength of evidence favoring interspinous spac-
ers compared to decompression surgery with or without fu-
sion regarding factors of disability and pain is low, meaning 
that “Further research is very likely to have an important 
impact on our confidence in the estimate of effect and is likely 
to change the estimate.”
•	  There was general surprise voiced that there is no direct 
comparison study between decompression surgery alone (in 
properly selected patients) and interspinous spacers without 
decompression. For various reasons the higher-grade evi-
dence relies on comparisons, such as interspinous spacers 
versus nonoperative modalities, decompression and fusion 
versus decompression and surgical decompression versus 
nonoperative treatment. The absence of the most compelling 
form of comparison studies—decompression alone versus 
interspinous spacer for more stable forms of stenosis and 
decompression and fusion versus decompression and inter-
spinous spacer for more unstable forms of stenosis—was 
quoted as being ”lamentable” and ”overdue for correction.”
•	  The absence of clinically relevant direct comparison studies 
necessitated a ‘network analysis’ with its inherent shortcom-
ings of error through heterogeneity of its study cohorts and 
lower level of familiarity to a clinician community. 
•	  The short-term follow-up of studies with interspinous spac-
ers (12 months) was noted to likely underreport complica-
tions, such as device loosening and need for more complex re-
vision surgery for patients with interspinous devices, which 
would appear to be more likely to fail with time. 
•	  The impact of patients’ complications with interspinous 
devices as expressed in invasiveness of potential corrective 
surgery compared to less expensive and simple decompres-
sion surgery is presently not understood. 
•	  The potential for financial conflict of interest affecting several 
authors related to the development and subsequent market-
ing of certain interspinous devices was pointed out. To date 
there are no prospective comparison studies from financially 
disinterested third-party groups.
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Fig 3e The intraoperative site revealed extensive foreign body debris (dark spots) and 
abundant reactive connective tissue build up around the area of the interspinous spacers.
Case example
(Case provided by Jens Chapman)
Two years after L3/4 interspinous process-spacer placement a 
physically very active and healthy 65-year-old man presented 
with severe bilateral leg pain brought on by short-distance 
walking and relieved by bending and squatting (Fig 3a–c). At 
the time the procedure had brought substantial symptom relief, 
however progressive symptom recurrence was noted about 18 
months after the index procedure. The patient was found to have 
an X-Stop device at his L3/4 interspace with heterotopic bone 
formation surrounding the implant, as well as a subtle grade 1 
degenerative spondylolisthesis. 
The MRI scan revealed persistent significant central stenosis 
with facet hypertrophy and lateral recess compromise (Fig 3d).
Because of failure of nonoperative treatment the patient un-
derwent removal of the device and simple midline-sparing 
hemilaminotomies with partial facetectomies through a key-
hole laminotomy approach (Fig 3e). Abundant heterotopic 
bone surrounding the implant was carefully removed, while 
avoiding injury to the ligaments. Since decompressive surgery 
the patient experienced complete relief of lower extremity and 
back symptoms and return to activities of daily living including 
competitive golf 6 months to date. 
This case illustrates some concerns about interspinous spacers. 
The role of simple soft-tissue–sparing decompression surgery, 
while avoiding destabilizing measures, compared to an implant-
based nonfusion procedure remains to be established and cannot 
be concluded based on the current state of the literature. Does a 
nonfusion device in fact set up patients for more revision surger-
ies in the intermediate and longer run compared to simple de-
compression or fusion surgery in appropriately selected patient? 
Another question worth debating is how long does a satisfactory 
result in elective spine surgery have to last to be counted as a 
success? Alternatively, when is a revision procedure performed 
at an index level a complication? This case certainly illustrates 
some of the many unanswered questions. 
Fig 3a Preoperative x-ray (AP view). Fig 3b Preoperative x-ray (extension). Fig 3c Preoperative x-ray (flexion).
Fig 3d Magnetic resonance imaging (axial).
